Lv31
390 积分 2021-09-18 加入
Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial
2小时前
已完结
Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma
2个月前
已完结
Clinical Remission Outcome in Patients with Severe Asthma with an Eosinophilic Phenotype (SA-EP) Receiving Mepolizumab: A Post-Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial
2个月前
已完结
Overall Response to Anti-IL-5/Anti-IL5-Rα Treatment in Severe Asthma Does Not Depend on Initial Bronchodilator Responsiveness
2个月前
已完结
Omalizumab treatment reduces asthma exacerbations regardless of airway bronchodilator reversibility
2个月前
已完结
Effectiveness of omalizumab as treatment of allergic pulmonary aspergillosis in patients with cystic fibrosis and asthma
2个月前
已完结
Influence of baseline bronchodilator reversibility and blood eosinophils on lung function in patients with asthma following omalizumab
2个月前
已关闭
Anti–Interleukin-5 Therapy Is Associated with Attenuated Lung Function Decline in Severe Eosinophilic Asthma Patients From the Belgian Severe Asthma Registry
2个月前
已完结
Biologic treatments for severe asthma: 4 year experience of a single medical center
2个月前
已关闭
WITHDRAWN: Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM study
2个月前
已关闭
皖公网安备34019202002308
